Barclays PLC Boosts Holdings in Aphria Inc (NYSE:APHA)
Posted by Floyd Graber on Dec 31st, 2019
Barclays PLC boosted its holdings in shares of Aphria Inc (NYSE:APHA) by 87.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,677 shares of the company’s stock after acquiring an additional 22,305 shares during the period. Barclays PLC’s holdings in Aphria were worth $248,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Synovus Financial Corp grew its stake in shares of Aphria by 56.9% in the 2nd quarter. Synovus Financial Corp now owns 5,514 shares of the company’s stock valued at $39,000 after buying an additional 2,000 shares during the period. Capital Investment Advisory Services LLC grew its stake in shares of Aphria by 2,233.3% in the 2nd quarter. Capital Investment Advisory Services LLC now owns 7,000 shares of the company’s stock valued at $43,000 after buying an additional 6,700 shares during the period. Tower Research Capital LLC TRC grew its stake in shares of Aphria by 76.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 6,248 shares of the company’s stock valued at $44,000 after buying an additional 2,698 shares during the period. First Allied Advisory Services Inc. purchased a new stake in shares of Aphria in the 3rd quarter valued at approximately $57,000. Finally, BerganKDV Wealth Management LLC grew its stake in shares of Aphria by 2,162.5% in the 2nd quarter. BerganKDV Wealth Management LLC now owns 9,050 shares of the company’s stock valued at $63,000 after buying an additional 8,650 shares during the period. 9.60% of the stock is owned by institutional investors.
Shares of APHA stock opened at $4.73 on Tuesday. The firm’s 50 day moving average price is $4.79 and its 200-day moving average price is $5.76. Aphria Inc has a one year low of $3.76 and a one year high of $10.95. The firm has a market cap of $1.20 billion, a P/E ratio of -43.00 and a beta of 2.75.
Aphria (NYSE:APHA) last issued its quarterly earnings data on Tuesday, October 15th. The company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.03) by $0.10. The company had revenue of $126.10 million during the quarter, compared to analyst estimates of $131.15 million. The business’s quarterly revenue was up 848.1% on a year-over-year basis. Analysts forecast that Aphria Inc will post 0.06 EPS for the current fiscal year.
Several analysts have recently weighed in on APHA shares. Jefferies Financial Group set a $8.30 price target on shares of Aphria and gave the company a “buy” rating in a research note on Tuesday, October 15th. Cantor Fitzgerald started coverage on shares of Aphria in a research note on Tuesday, November 5th. They issued an “overweight” rating and a $10.40 price target for the company. CIBC reissued a “sell” rating and issued a $6.50 price target on shares of Aphria in a research note on Wednesday, October 16th. Pi Financial set a $9.00 price objective on shares of Aphria and gave the stock a “buy” rating in a report on Tuesday, October 15th. Finally, ValuEngine lowered shares of Aphria from a “buy” rating to a “hold” rating in a report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and seven have issued a buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $12.03.
About Aphria
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
